Evidence-Based Reviews

Psychotherapy for psychiatric disorders: A review of 4 studies

Author and Disclosure Information

 

References

4. Janssen L, Kan CC, Carpentier PJ, et al. Mindfulness-based cognitive therapy v. treatment as usual in adults with ADHD: a multicentre, single-blind, randomised controlled trial. Psychol Med. 2019;49(1):55-65.

There is empirical support for using psychotherapy to treat attention-deficit/hyperactivity disorder (ADHD). Although medication management plays a leading role in treating ADHD, Janssen et al4 conducted a multicenter, single-blind trial comparing mindfulness-based cognitive therapy (MBCT) vs treatment as usual (TAU) for ADHD.

The aim of this study was to determine the efficacy of MBCT plus TAU vs TAU only in decreasing symptoms of adults with ADHD.4

Study design

  • This multicenter, single-blind randomized controlled trial was conducted in the Netherlands. Participants (N = 120) met criteria for ADHD and were age ≥18. Patients were randomly assigned to MBCT plus TAU (n = 60) or TAU only (n = 60). Patients in the MBCT plus TAU group received weekly group therapy sessions, meditation exercises, psychoeducation, and group discussions. Patients in the TAU-only group received pharmacotherapy and psychoeducation.4
  • Blinded clinicians used the Connors’ Adult ADHD Rating Scale to assess ADHD symptoms.4
  • Secondary outcomes were determined by self-reported questionnaires that patients completed online.4
  • All statistical analyses were performed on an intention-to-treat sample as well as the per protocol sample.4

Outcomes

  • The primary outcome was ADHD symptoms rated by clinicians. Secondary outcomes included self-reported ADHD symptoms, executive functioning, mindfulness skills, positive mental health, and general functioning. Outcomes were examined at baseline and then at post treatment and 3- and 6-month follow-up.4
  • Patients in the MBCT plus TAU group had a significant decrease in clinician-rated ADHD symptoms that was maintained at 6-month follow-up. More patients in the MBCT plus TAU group (27%) vs patients in the TAU group (4%) showed a ≥30% reduction in ADHD symptoms. Compared with patients in the TAU group, patients in the MBCT plus TAU group had significant improvements in ADHD symptoms, mindfulness skills, and positive mental health at post treatment and at 6-month follow-up. Compared with those receiving TAU only, patients treated with MBCT plus TAU reported no improvement in executive functioning at post treatment, but did improve at 6-month follow-up.4

Continue to: Conclusion

Pages

Recommended Reading

A prescription for ‘deprescribing’: A case report
MDedge Psychiatry
Early lead exposure tied to greater psychopathology in adulthood
MDedge Psychiatry
Mood and behavior are different targets for irritability in children
MDedge Psychiatry
Accurately predicting ADHD’s trajectory deemed almost impossible
MDedge Psychiatry
Eczema increases the risk of impaired mental health among children
MDedge Psychiatry
Amphetamine tied to higher risk of new-onset psychosis than methylphenidate
MDedge Psychiatry
About one in four youths prescribed stimulants also use the drugs nonmedically
MDedge Psychiatry
Most preschoolers with signs of ADHD aren’t ready for primary school
MDedge Psychiatry
Strategies for improving ADHD medication adherence
MDedge Psychiatry
Four genetic variants link psychotic experiences to multiple mental disorders
MDedge Psychiatry